CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
Aug 19, 2025 15:00 HKT |  |
|
康哲药业（867.HK，8A8.SG）上半年营收净利双升 战略转型跑出增长新动能
Aug 19, 2025 11:53 HKT | |
|
康哲藥業（867.HK，8A8.SG）上半年營收淨利雙升 戰略轉型跑出增長新動能
Aug 19, 2025 11:53 HKT | |
|
NMPA已受理亿胜生物关于EB12-20145P（HLX04-O）用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
Aug 13, 2025 21:25 HKT |  |
|
NMPA已受理億勝生物關於EB12-20145P（HLX04-O）用於治療濕性年齡相關性黃斑變性的生物製品許可申請
Aug 13, 2025 20:24 HKT | |
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 20:24 HKT | |
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT | |
|
亿胜生物多剂量地夸磷索钠滴眼液获中国国家药品监督管理局批准上市
Jul 25, 2025 10:52 HKT | |
|
億勝生物多劑量地誇磷索鈉滴眼液獲中國國家藥品監督管理局批准上市
Jul 25, 2025 10:52 HKT | |
|
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China
Jul 25, 2025 10:52 HKT | |
|
冠科生物圣地亚哥实验室获 CLIA 认证 增强临床试验支持能力
Jul 23, 2025 09:00 HKT |  |
|
冠科生物聖地牙哥實驗室獲 CLIA 認證 增強臨床試驗支援能力
Jul 23, 2025 09:00 HKT | |
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT | |
|
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索
Jul 18, 2025 13:00 HKT | |
|
耀啟新程！康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 17:05 HKT | |
|
耀启新程！康哲药业今日于新加坡交易所主板实现二次上市
Jul 15, 2025 16:53 HKT | |
|
Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Jun 25, 2025 21:27 HKT |  |
|
康哲藥業建議於新加坡交易所第二上市
Jun 25, 2025 18:13 HKT | |
|
康哲药业建议于新加坡交易所第二上市
Jun 25, 2025 17:24 HKT | |
|
康希諾重磅推出優佩欣疫苗 為兒童健康保駕護航的創新之選
Jun 21, 2025 12:09 HKT | |
|